John_5613542 (@johnls1974) header
John_5613542 (@johnls1974) profile picture
Florida
Joined February 2013
Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)Photo by John_5613542 (@johnls1974)
Pick one. Best return for 2023...$ASTA, $HVCW
16%$ASTA
84%$HVCW
79 votes • Final results
3
1
29
John_5613542 retweeted
Stop using age as an excuse. Ray Kroc (52) built McDonald’s.
Colonel Sanders (62) built KFC.
Sam Walton (50+) scaled Walmart.
Bernie Marcus (50) built Home Depot. You’re not late.
You’re undisciplined. Fix it.
2
2
1
36
1,541
$ADHC--0016 up and level 2 clearing up to 002s On news watch for next week. Expecting updates soon on its FDA pending GlucoGuard Break Through Device (BTD) otcmarkets.com/stock/ADHC/ne… quadroace.blogspot.com $AHRO $AIBT $BLEG $CLNV $CYBL $DRCR $ICTY $IFUS $IGPK $ILUS $IQST $KITL $KOAN $LUDG $MVCO $QIND $SAML $SFWJ $SNBH $TLIF $VGTL $ECOX $vrsrf $vhai
1
1
7
542
$ADHC on Alert - GlucoGuard Receives Scope of Work (SOW) Proposal from Arete Bioscience for FDA Recommended Sleep Study Newsfile Tue, October 14, 2025 2 Prong Proposal Includes a 10 Patient, Physician Monitored Sleep Study to Observe Glucose Aspiration Risk and Record Effect of Blood Sugar Level Before and After Administration of Glucose newsfilecorp.com/release/270… @ADHCMANAGEMENT
3
7
185
🚨 NEW DD DROP — $ADHC 🚨 Tiny cap. MASSIVE credentials. 💡 Partnered w/ $DXCM (Dexcom – $26B industry leader) 🧠 Led by Johns Hopkins + Northwestern PhDs 🩺 FDA labeled GlucoGuard “Breakthrough Tech” 💰 No toxic debt | $4.2M market cap 🎥 Watch the full breakdown ⬇️
6
17
8
37
9,080
John_5613542 retweeted
$ADHC 1. Management team is Nasdaq quality, MD, PhD, JD 2. Partner with $26 Billion industry leader DXCM for CGM 3. Patented technology 4. University support from ASU and UC Irvine 5. Favorable FDA review Indicating Glucoguard satisfies an unmet need, managing nocturnal
1
3
2
12
521
🔥 $ADHC secures $5M institutional funding to advance GlucoGuard toward FDA approval + expand w/ DexCom. 🚀 Massive upside ahead. I’m BULLISH AF! #ADHC #GlucoGuard #DexCom #Biotech #SmallCaps #Investing #Bullish #FDA $ADHC
43
$ADHC 💣💣💣💣💣
This quoted post is unavailable.
1
8
669
All aboard! The $ADHC train is spewing steam and ready to leave the station. Shout out to @StockPicksNYC
🤖 Made with AI
3
7
2
28
1,993
$ADHC 0016 thinning .breakout over 002 this will be fun to watch once groups realize how undervalued it is. FDA approval of its GlucoGuard ..then big pharma buyout will be on table...only 1.4b out with no toxic debt EXPECTING MUCH NEWS THIS WEEK>>> WHALES JUST STARTED NIBBLING TODAY $igpk $twoh $adhc $dtii $gtvh $vrsrf $vhai $tsla $bmnr $clnv $koan $kegs $kitl @greatstockpicks @SarwanJohn @StockPicksNYC
4
1
13
731
Fourth quarter play right here...Don't miss this one..Good things cooking! #ADHC @ADHCMANAGEMENT $OTCFI
This quoted post is unavailable.
1
169
BREAKING: Security camera footage has emerged showing the alleged killer of Charlie Kirk minutes before the assassination, captured by a homeowner’s camera. The individual appears to be limping, possibly to conceal a firearm.
15
65
4
119
6,890
John_5613542 retweeted
Can the @FBI please look into this? Posted just over 24 hours ago.
740
7,823
567
18,068
460,566
John_5613542 retweeted
$adhc The whole chart is moving together Just saying
1
2
7
313
John_5613542 retweeted
2
9
449
$ADHC 💣💣💣💣💥
$ADHC American Diversified Holdings Corporation (ADHC) Provides Udpate on Arete Bioscience GlucoGuard Design Project Arete Engineering team has reviewed all previous engineering schematics including patent filings and other intellectual property, incorporated The Food and Drug Administration's (FDA) recommendations into the design plans and created an indepth CAD plan for the next stage of development. finance.yahoo.com/news/ameri…
5
212
$ADHC 🔥 ADHC is a medical device company developing GlucoGuard, a patent-pending nocturnal glucose monitoring and delivery system for diabetic patients. The system helps prevent the dangerous effects of hypoglycemia "low blood sugar" during sleep, including the potentially fatal "Death in Bed" phenomenon. Collaborating with a leading U.S. research university, a prominent biomedical engineering firm, and a major CGM company, GlucoGuard is at the forefront of diabetes management technology. $HOLO $NLST $LODE $AITX $HMBL $LTNC $OZSC $AIAD $GEVO $CYBL $GGII $IGEX
1
8
162